[抗病毒治疗：I型干扰素的利弊？] - Suppr

Suppr

超能文献

[Anti-viral treatment: pro or cons type I IFN?].

作者信息

Whitehead Piers, Drouet Béatrice, Zagury Daniel, Bensussan Armand

机构信息

Neovacs, 3-5, impasse Reille, 75014 Paris, France.

出版信息

Med Sci (Paris). 2013 Oct;29(10):836-9. doi: 10.1051/medsci/20132910008. Epub 2013 Oct 18.

DOI:10.1051/medsci/20132910008

PMID:24148119

Abstract

摘要

相似文献

[Anti-viral treatment: pro or cons type I IFN?].

Med Sci (Paris). 2013 Oct;29(10):836-9. doi: 10.1051/medsci/20132910008. Epub 2013 Oct 18.

[The first answer to viral infections: type I interferon].

Berl Munch Tierarztl Wochenschr. 2004 Jul-Aug;117(7-8):252-65.

Targeting of type I interferon in systemic autoimmune diseases.

Transl Res. 2015 Feb;165(2):296-305. doi: 10.1016/j.trsl.2014.10.005. Epub 2014 Oct 16.

Overview of the biology of type I interferons.

Arthritis Res Ther. 2010;12 Suppl 1(Suppl 1):S1. doi: 10.1186/ar2881. Epub 2010 Apr 14.

[Interferon therapy in chronic viral hepatitis; an autoimmunity dilemma].

Przegl Lek. 2007;64(3):148-52.

Type I interferon and autoimmune disease.

Autoimmunity. 2003 Dec;36(8):445-6. doi: 10.1080/08916930310001625961.

The type I interferon system in the development of lupus.

Semin Immunol. 2011 Apr;23(2):113-21. doi: 10.1016/j.smim.2011.01.009. Epub 2011 Feb 2.

Interferon regulatory factors: beyond the antiviral response and their link to the development of autoimmune pathology.

Autoimmun Rev. 2011 Dec;11(2):98-103. doi: 10.1016/j.autrev.2011.08.006. Epub 2011 Aug 18.

Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature.

Front Immunol. 2021 Nov 30;12:757249. doi: 10.3389/fimmu.2021.757249. eCollection 2021.

Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.

Minerva Gastroenterol Dietol. 2005 Mar;51(1):55-61.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Anti-viral treatment: pro or cons type I IFN?].

Med Sci (Paris). 2013 Oct;29(10):836-9. doi: 10.1051/medsci/20132910008. Epub 2013 Oct 18.

[The first answer to viral infections: type I interferon].

Berl Munch Tierarztl Wochenschr. 2004 Jul-Aug;117(7-8):252-65.

Targeting of type I interferon in systemic autoimmune diseases.

Transl Res. 2015 Feb;165(2):296-305. doi: 10.1016/j.trsl.2014.10.005. Epub 2014 Oct 16.

Overview of the biology of type I interferons.

Arthritis Res Ther. 2010;12 Suppl 1(Suppl 1):S1. doi: 10.1186/ar2881. Epub 2010 Apr 14.

[Interferon therapy in chronic viral hepatitis; an autoimmunity dilemma].

Przegl Lek. 2007;64(3):148-52.

Type I interferon and autoimmune disease.

Autoimmunity. 2003 Dec;36(8):445-6. doi: 10.1080/08916930310001625961.

The type I interferon system in the development of lupus.

Semin Immunol. 2011 Apr;23(2):113-21. doi: 10.1016/j.smim.2011.01.009. Epub 2011 Feb 2.

Interferon regulatory factors: beyond the antiviral response and their link to the development of autoimmune pathology.

Autoimmun Rev. 2011 Dec;11(2):98-103. doi: 10.1016/j.autrev.2011.08.006. Epub 2011 Aug 18.

Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature.

Front Immunol. 2021 Nov 30;12:757249. doi: 10.3389/fimmu.2021.757249. eCollection 2021.

Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.

Minerva Gastroenterol Dietol. 2005 Mar;51(1):55-61.